lang="en">
TruBridge Financial AnalysisKey Takeaways
- TruBridge TBRG reported a slight decline in fourth-quarter revenue to $87.2 million from $88.1 million the previous year.
- The company is focusing on enhancing earnings quality and operational efficiency through strategic cost management and offshoring.
- TruBridge's financial health shows mixed signals with strong gross margins but concerning Altman Z-Score indicating potential financial distress.
Company Overview and Recent Developments
TruBridge (TBRG) recently announced its fourth-quarter revenue of $87.2 million, marking a slight decrease from the $88.1 million reported in the same period last year. Despite this dip, CEO Chris Fowler emphasized the company's progress in improving earnings quality and operational framework through effective cost management and strategic offshoring. These initiatives are expected to enhance profit margins and shareholder value.
TruBridge Inc is a provider of healthcare solutions and services for community hospitals, clinics, and other healthcare systems. The company operates in the healthcare sector, specifically within the healthcare providers and services industry. With a market capitalization of approximately $219.73 million, TruBridge is positioned as a key player in its niche market.
Financial Health Analysis
TruBridge's financial metrics present a mixed picture of its current health:
- Revenue Growth: The company reported total revenue of $347.27 million over the trailing twelve months, with a 3-year revenue growth rate of 6.9%.
- Profitability: TruBridge's gross margin stands at 52.81%, while its net margin is 1.03%. The operating margin is 6.45%, indicating moderate profitability.
- Balance Sheet: The company maintains a current ratio of 1.91 and a debt-to-equity ratio of 0.93, suggesting a stable financial position.
- Warning Signs: The Altman Z-Score of 1.74 places TruBridge in the distress zone, indicating a potential risk of financial distress within the next two years.
Valuation and Market Sentiment
TruBridge's valuation metrics provide insights into its market positioning:
- Valuation Ratios: The company's P/E ratio is 77.05, while the P/S ratio is 0.63, and the P/B ratio is 1.22. These figures suggest that the stock is trading at a relatively high valuation compared to its historical ranges.
- Analyst Targets: The average target price for TruBridge is $23.67, indicating potential upside from current levels.
- Technical Indicators: The RSI (14) is 21.88, suggesting that the stock is currently oversold.
- Ownership: Institutional ownership stands at 45.54%, with insider ownership at 14.57%, reflecting a significant level of confidence from stakeholders.
Risk Assessment
TruBridge faces several risks that investors should consider:
- Financial Health Grades: The company's Piotroski F-Score is 8, indicating a strong financial position, while the Beneish M-Score of -2.94 suggests it is unlikely to be a manipulator.
- Sector-Specific Risks: As a healthcare provider, TruBridge is subject to regulatory changes and reimbursement rate fluctuations.
- Volatility: The stock's beta of 0.63 indicates lower volatility compared to the broader market.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
